DJIA 17,751.39 121.12 0.69%
NASDAQ 5,111.73 22.53 0.44%
S&P 500 2,108.57 15.32 0.73%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)

125.62 -2.68 (-2.09%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRTX $125.62 -2.09%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $128.28
Previous Close $128.30
Daily Range $125.27 - $128.98
52-Week Range $84.41 - $137.50
Market Cap $30.6B
P/E Ratio -43.20
Dividend (Yield) $0.00 (0.0%)
Volume 1,784,875
Average Daily Volume 1,645,636
Current FY EPS -$2.00

Sector

Healthcare

Industry

Drug Makers

Vertex Pharmaceuticals (VRTX) Description

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Website: http://www.vrtx.com/

News & Commentary Rss Feed

Vertex Pharmaceuticals Rolls Along

Solid quarter, but Orkambi sales in future quarters will dictate the biotech’s fate.

Vertex Pharmaceuticals (VRTX) Jeffrey M. Leiden on Q2 2015 Results - Earnings Call Transcript

Trade-Ideas: Vertex Pharmaceuticals (VRTX) Is Today's Post-Market Leader Stock

Biotech Stock Roundup: Biogen Down on Tecfidera Issues, Regeneron's Praluent Gets FDA Nod - Analyst

Biotech Stock Roundup: Biogen Down on Tecfidera Issues, Regeneron's Praluent Gets FDA Nod - Analyst Blog

Earnings Reaction History: Vertex Pharmaceuticals Incorporated, 66.7% Follow-Through Indicator, 3.8%

Earnings Reaction History: Vertex Pharmaceuticals Incorporated, 66.7% Follow-Through Indicator, 3.8% Sensitive

The Secret to Vertex Pharmaceuticals' Success

Originally set out to treat the hepatitis C market, Vertex has successfully pivoted its focus to the cystic fibrosis market instead, where it looks poised for strong growth.

Will Vertex (VRTX) Surprise with a Lower Loss in Q2? - Analyst Blog

An Analysis Of Intercept Pharma, An Innovator In Serious Liver Diseases With Unmet Needs

Nasdaq 100 Movers: AAL, CELG

S&P 500 Movers: YUM, CELG

See More VRTX News...

VRTX's Top Competitors

VRTX $125.62 (-2.09%)
Current stock: VRTX
AMGN $171.47 (-0.74%)
Current stock: AMGN
GILD $115.71 (2.33%)
Current stock: GILD
BIIB $313.34 (-2.06%)
Current stock: BIIB